Search the Newsreel

Brainsway (NASDAQ:BWAY) Downgraded to Hold Rating by Wall Street Zen

Wall Street Zen has downgraded Brainsway (NASDAQ:BWAY) from "buy" to "hold," despite other brokerages maintaining bullish ratings. The company still holds a consensus "Buy" rating with an average target price of $15.67 from analysts, and recently surpassed earnings expectations. Brainsway, a medical device company, …

H.C. Wainwright reiterates Brainsway stock rating on strategic investments By Investing.com

H.C. Wainwright reiterated a Buy rating and a $17.00 price target for Brainsway (NASDAQ:BWAY) following Brainsway's strategic minority equity investments in Radial Health and Sound Minds Behavioral. These investments are part of Brainsway's long-term plan to drive revenue and equity value. The company has …

Bull of the Day: Brainsway (BWAY)

Brainsway (BWAY) is a medical device company treating mental health disorders from major depressive disorder and OCD to substance abuse and cigarette addiction. Its proprietary Deep Transcranial Magnetic Stimulation (Deep TMS) platform uses a rapidly changing magnetic field to induce a small electrical current …

Brainsway (BWAY) is on the Move, Here's Why the Trend Could be Sustainable

Price-Driven Insight from (BWAY) for Rule-Based Strategy

This article provides a price-driven analysis for Brainsway Ltd. (NASDAQ: BWAY), highlighting strong near and mid-term sentiment, resistance testing, and an exceptional risk-reward short setup. It details three AI-generated institutional trading strategies—Position Trading, Momentum Breakout, and Risk Hedging—with specific entry, target, and stop loss …

BTIG Initiates Brainsway(BWAY.US) With Buy Rating, Announces Target Price $18

BTIG has initiated coverage on Brainsway (BWAY.US) with a Buy rating. The firm has set a target price of $18 for the company's shares. This initiation signals analyst confidence in Brainsway's future performance.

BrainsWay Ltd (BWAY) Stock Up 4.9% but GF Value Says Overvalued -- GF Score: 65/100

BrainsWay Ltd (BWAY) shares rose 4.9% to $16.53, a significant increase year-to-date and over the past year. However, GuruFocus's GF Value™ indicates the stock is 138.2% overvalued at this price, suggesting a lack of margin of safety. While its GF Score™ of 65/100 (Above …

BrainsWay Announces Strategic Investment in Radial Health, Inc.

BrainsWay has invested $3 million in Radial Health, Inc., a management services organization that supports a network of Brain Medicine clinics. This minority equity investment is part of Radial's Series A financing and aims to expand access to advanced noninvasive mental health treatments like …

Brainsway Ltd. Sponsored ADR (NASDAQ:BWAY) Given Consensus Rating of "Buy" by Analysts

Five analysts have issued a consensus "Buy" rating for Brainsway Ltd. Sponsored ADR (NASDAQ:BWAY), with an average 12-month price target of $15.67. Recent analyst actions, including new coverage and upgrades, highlight positive sentiment. The company also surpassed Q1 earnings expectations, reporting an EPS of …

Brainsway (NASDAQ:BWAY) Coverage Initiated by Analysts at BTIG Research

BTIG Research has initiated coverage on Brainsway (NASDAQ:BWAY) with a "buy" rating and an $18 price target, indicating a 14.4% potential upside. This positive sentiment aligns with other recent analyst upgrades and the company's stronger-than-expected quarterly earnings, which surpassed estimates for both EPS and …

BrainsWay (NASDAQ: BWAY) makes $3M strategic bet on Radial Health

BrainsWay Ltd. announced a $3 million minority equity investment in Radial Health, Inc., a management services organization that supports a network of Brain Medicine clinics. This strategic investment is part of Radial's Series A financing and aligns with BrainsWay's strategy to expand awareness and …

A $3M BrainsWay Investment Is Expected to Support Radial's M&A Exploration

BrainsWay (BWAY) has announced a $3 million strategic minority equity investment in Radial Health, a management services organization focusing on Brain Medicine clinics. This investment is part of Radial's Series A financing round and aligns with BrainsWay's strategy to expand access to advanced psychiatric …

BrainsWay invests $3 million in Radial Health network By Investing.com

BrainsWay Ltd. has announced a $3 million minority equity investment in Radial Health, Inc., a management services organization focused on Brain Medicine clinics. This investment, part of Radial's Series A financing round, aims to expand awareness and access to noninvasive mental health treatments and …

BrainsWay Ltd. (BWAY) Q1 2026 Earnings: EPS Surpasses Estimates by Nearly 7%, Shares Rally 6% - One-Time Loss Impact

BrainsWay Takes Minority Stake in Sound Minds Behavioral to Expand Interventional Psychiatry Reach

BrainsWay has made a $500,000 minority investment in Sound Minds Behavioral, an outpatient mental health platform. This strategic move aims to expand BrainsWay's presence in the Mid-Atlantic market and increase access to innovative mental health care, while BrainsWay continues to focus on its Deep …

Brainsway stock rating reiterated at Buy by H.C. Wainwright

H.C. Wainwright has reiterated a Buy rating on Brainsway (NASDAQ:BWAY) with a $17.00 price target, following the company's strategic equity investment in Sound Minds Behavioral. The medical device company's stock has shown strong performance, surging 156% over the past year. Brainsway's financial flexibility, with …

BRSYF SEC Filings - Brainsway 10-K, 10-Q, 8-K Forms

This article provides a comprehensive overview of Brainsway (BRSYF) SEC filings, including 10-K, 10-Q, and 8-K forms, focusing on recent insider ownership reports. It details the equity holdings, stock options, and restricted stock units of several key executives and directors, such as David Zacut, …

BrainsWay invests USD 500,000 for minority stake in Sound Minds Behavioral

BrainsWay will invest $500,000 for a minority stake in Sound Minds Behavioral, an outpatient behavioral health platform. This investment is part of a strategic equity financing round. The original content was published by Brainsway Ltd. via GlobeNewswire.

Sound Minds Behavioral announced that it expects to receive $0.5 million in funding from BrainsWay Ltd.

Sound Minds Behavioral announced it expects to receive $0.5 million in funding from BrainsWay Ltd. This investment, confirmed on July 16, 2026, involves BrainsWay Ltd. acquiring a minority equity stake in Sound Minds Behavioral. The security issued for this transaction will be a preferred, …

BrainsWay invests $500,000 in Sound Minds Behavioral By Investing.com

BrainsWay Ltd. announced a $500,000 investment for a minority stake in Sound Minds Behavioral, an outpatient behavioral health platform operating in several Mid-Atlantic states. This strategic investment allows BrainsWay to support partners' growth while focusing on its Deep TMS technology. The company, which has …

BrainsWay (NASDAQ: BWAY) invests $500K in Sound Minds Behavioral

BrainsWay Ltd. announced a strategic minority investment of $500,000 in Sound Minds Behavioral, an outpatient behavioral health platform. This investment, made through a preferred, annually compounding security, aims to expand access to interventional psychiatry solutions, leveraging BrainsWay's Deep Transcranial Magnetic Stimulation platform. Sound Minds …

Four-State Behavioral Health Platform Adds BrainsWay as Partner

BrainsWay (NASDAQ & TASE: BWAY) announced a strategic minority-stake investment of $500,000 in Sound Minds Behavioral, an outpatient behavioral health platform operating in Connecticut, Pennsylvania, New Jersey, and New York. This investment, structured as a preferred, annually compounding security, supports BrainsWay's strategy to partner …

BrainsWay Announces Minority-Stake Investment in Sound Minds Behavioral

BrainsWay Ltd., a leader in neurostimulation treatments for mental health, has announced a $500,000 minority-stake investment in Sound Minds Behavioral. This investment is part of BrainsWay's strategy to partner with growth-oriented mental health providers to increase access to transformative care. Sound Minds Behavioral is …

Brainsway (NASDAQ:BWAY) Upgraded to Strong-Buy at Zacks Research

Zacks Research has upgraded Brainsway (NASDAQ:BWAY) from a "hold" to a "strong-buy" rating, reflecting a generally bullish outlook from analysts. The medical device company, specializing in non-invasive neuromodulation therapies, reported better-than-expected Q1 earnings with EPS of $0.12 and revenue of $15.53 million, surpassing estimates. …

BrainsWay (BWAY) Gains 2% as Shares Approach Key Resistance - Demand Zone

BrainsWay opens May 13 with earnings release, 8:30 a.m. webcast

BWAY: 2025 revenue rose 27% to $52.2M, net income reached $7.6M, and FDA clearances expanded